Last Update 10 Jun 26
FFARM: Future Upside Will Rely On €0.30 Dividend Policy
Analysts have kept their €7.88 price target for ForFarmers unchanged, reflecting steady assumptions on fair value, discount rate, revenue growth, profit margin and future P/E.
What's in the News
- On April 16, 2026, the Board of Directors authorized a share buyback plan for ForFarmers N.V., according to company key developments.
- ForFarmers N.V. announced a share repurchase program of up to 300,000 shares with a maximum amount of €2.2 million to meet obligations under share-related remuneration and employee participation plans running until 2027. The program is valid until December 31, 2026, based on key developments data.
- The General Meeting of Shareholders on April 16, 2026 approved a dividend of €0.30 per ordinary share, paid fully in cash after 15% withholding tax. The ex-dividend date is April 20, 2026 and the payment date is May 4, 2026, as reported in key developments.
Valuation Changes
- Fair Value remained steady at €7.88 per share, with no change in the underlying estimate.
- The Discount Rate was effectively unchanged at 5.50%, indicating a consistent required return assumption.
- Revenue Growth was kept at roughly 1.17%, with only a very small numerical adjustment that does not alter the headline figure.
- The Net Profit Margin was maintained at about 1.98%, with only a marginal numerical refinement.
- The Future P/E remained stable at 13.03x, reflecting no practical change in the earnings multiple assumption.
Key Takeaways
- Strategic expansion, sustainability initiatives, and operational efficiencies position the company for enhanced margins and long-term growth in evolving global protein markets.
- Strong financial flexibility enables continued investment and acquisitions to capitalize on industry consolidation and innovation opportunities.
- Reliance on acquisitions, regulatory pressures, market exits, and volatile joint ventures threaten growth, profitability, and long-term sustainability in key ForFarmers markets.
Catalysts
About ForFarmers- Provides feed solutions for conventional and organic livestock farming under the ForFarmers brand in the Netherlands, the United Kingdom, Germany, Poland, Belgium, and internationally.
- ForFarmers' ongoing capacity expansion in Poland and strengthened market positions across Germany and the UK position the company to directly benefit from sustained, long-term global growth in protein consumption, especially in Eastern Europe-supporting higher future revenues and growth rates.
- The company's established focus on sustainability (lower carbon footprint, circularity, biodiversity) and investments in co-product-based feed solutions enable penetration into premium, traceable feed markets and compliance with evolving food supply chain requirements, which should support margin expansion and revenue resilience.
- Bolt-on acquisitions (Van Triest) and formation of strong regional joint ventures (team agrar in Germany) create economies of scale and operational synergies, which are expected to enhance operating margins and long-term earnings growth as integration progresses.
- Tight operational expense controls-demonstrated by very limited like-for-like cost increases despite volume growth-and completed reorganizations (especially in the UK) are set to drive improved net margin and profitability going forward.
- The company's strong balance sheet and low net debt/EBITDA ratio provide flexibility to pursue further growth investments and acquisitions in an industry likely to reward scale and innovation, underpinning earnings and revenue expansion potential.
ForFarmers Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming ForFarmers's revenue will grow by 1.2% annually over the next 3 years.
- Analysts assume that profit margins will increase from 1.6% today to 2.0% in 3 years time.
- Analysts expect earnings to reach €64.6 million (and earnings per share of €0.72) by about June 2029, up from €49.9 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.2x on those 2029 earnings, up from 10.9x today. This future PE is lower than the current PE for the GB Food industry at 21.2x.
- Analysts expect the number of shares outstanding to grow by 1.28% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 5.5%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Government buyout schemes in the Netherlands are driving livestock farmers, especially in the pig sector, to exit the market, which is expected to reduce ForFarmers' compound feed volumes over the next 12-18 months and could lead to long-term revenue decline and margin pressure in one of its largest markets. (Impacts: Revenue, earnings)
- The ongoing volatility and underperformance of the HaBeMa commodity export business in Germany, which is part of ForFarmers' newly consolidated joint venture, exposes the company to fluctuating profits and increased earnings instability due to the inherent cyclicality and competitive pressures in commodity markets. (Impacts: Net margins, earnings)
- The company's volume growth in recent periods is heavily reliant on acquisitions (e.g., Van Triest, consolidation of team agrar/HaBeMa), while like-for-like (organic) growth remains modest, raising concerns that future growth may stall if acquisition opportunities dwindle or fail to deliver expected synergies. (Impacts: Revenue, top-line growth)
- Heightened regulatory pressure on sustainability, particularly around nitrogen emissions in the Dutch market and animal disease outbreaks in Poland, poses the risk of stricter operating requirements, higher compliance costs, and potential market contraction for traditional animal feed, threatening long-term competitiveness. (Impacts: Operating costs, net margin, revenue)
- The company's capital allocation is increasingly exposed to integration risks from recent M&A, and joint ventures, raising the prospect of elevated costs, operational complexity, or underachievement of expected synergies-which could ultimately weigh on profitability and returns on invested capital. (Impacts: Operating expenses, net margins, ROIC)
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €7.88 for ForFarmers based on their expectations of its future earnings growth, profit margins and other risk factors.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €3.3 billion, earnings will come to €64.6 million, and it would be trading on a PE ratio of 13.2x, assuming you use a discount rate of 5.5%.
- Given the current share price of €6.13, the analyst price target of €7.88 is 22.2% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on ForFarmers?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.